Background: Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor with infiltration of, on conventional imaging, normal-appearing brain parenchyma. Phosphorus magnetic resonance spectroscopy (31P-MRS) enables the investigation of different energy and membrane metabolites. The aim of this study is to investigate regional differences of 31P-metabolites in GBM brains. Methods: In this study, we investigated 32 patients (13 female and 19 male; mean age 63 years) with naïve GBM using 31P-MRS and conventional MRI. Contrast-enhancing (CE), T2-hyperintense, adjacent and distant ipsilateral areas of the contralateral brain and the brains of age- and gender-matched healthy volunteers were assessed. Moreover, the 31P-MRS results were correlated with quantitative diffusion parameters. Results: Several metabolite ratios between the energy-dependent metabolites and/or the membrane metabolites differed significantly between the CE areas, the T2-hyperintense areas, the more distant areas, and even the brains of healthy volunteers. pH values and Mg2+ concentrations were highest in visible tumor areas and decreased with distance from them. These results are in accordance with the literature and correlated with quantitative diffusion parameters. Conclusions: This pilot study shows that 31P-MRS is feasible to show regional differences of energy and membrane metabolism in brains with naïve GBM, particularly between the different "normal-appearing" regions and between the contralateral hemisphere and healthy controls. Differences between various genetic mutations or clinical applicability for follow-up monitoring have to be assessed in a larger cohort.
Background: Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor with infiltration of, on conventional imaging, normal-appearing brain parenchyma. Phosphorus magnetic resonance spectroscopy (31P-MRS) enables the investigation of different energy and membrane metabolites. The aim of this study is to investigate regional differences of 31P-metabolites in GBM brains. Methods: In this study, we investigated 32 patients (13 female and 19 male; mean age 63 years) with naïve GBM using 31P-MRS and conventional MRI. Contrast-enhancing (CE), T2-hyperintense, adjacent and distant ipsilateral areas of the contralateral brain and the brains of age- and gender-matched healthy volunteers were assessed. Moreover, the 31P-MRS results were correlated with quantitative diffusion parameters. Results: Several metabolite ratios between the energy-dependent metabolites and/or the membrane metabolites differed significantly between the CE areas, the T2-hyperintense areas, the more distant areas, and even the brains of healthy volunteers. pH values and Mg2+ concentrations were highest in visible tumor areas and decreased with distance from them. These results are in accordance with the literature and correlated with quantitative diffusion parameters. Conclusions: This pilot study shows that 31P-MRS is feasible to show regional differences of energy and membrane metabolism in brains with naïve GBM, particularly between the different "normal-appearing" regions and between the contralateral hemisphere and healthy controls. Differences between various genetic mutations or clinical applicability for follow-up monitoring have to be assessed in a larger cohort.
Entities:
Keywords:
ATP; MRS; PCr; energy metabolism; glioblastoma; magnetic resonance spectroscopy
Authors: Xian-Feng Shi; Paul J Carlson; Young-Hoon Sung; Kristen K Fiedler; Lauren N Forrest; Tracy L Hellem; Rebekah S Huber; Seong-Eun Kim; Chun Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo Journal: Bipolar Disord Date: 2015-10-19 Impact factor: 6.744
Authors: Hamed Akbari; Luke Macyszyn; Xiao Da; Michel Bilello; Ronald L Wolf; Maria Martinez-Lage; George Biros; Michelle Alonso-Basanta; Donald M OʼRourke; Christos Davatzikos Journal: Neurosurgery Date: 2016-04 Impact factor: 4.654
Authors: Choukri Mekkaoui; Philippe Metellus; William J Kostis; Roberto Martuzzi; Fabricio R Pereira; Jean-Paul Beregi; Timothy G Reese; Todd R Constable; Marcel P Jackowski Journal: PLoS One Date: 2016-01-13 Impact factor: 3.240
Authors: Andreas Korzowski; Nina Weckesser; Vanessa L Franke; Johannes Breitling; Steffen Goerke; Heinz-Peter Schlemmer; Mark E Ladd; Peter Bachert; Daniel Paech Journal: Front Neurol Date: 2021-12-23 Impact factor: 4.003
Authors: Malik Galijasevic; Ruth Steiger; Stephanie Mangesius; Julian Mangesius; Johannes Kerschbaumer; Christian Franz Freyschlag; Nadja Gruber; Tanja Janjic; Elke Ruth Gizewski; Astrid Ellen Grams Journal: Cancers (Basel) Date: 2022-06-29 Impact factor: 6.575
Authors: Jinyuan Zhou; Moritz Zaiss; Linda Knutsson; Phillip Zhe Sun; Sung Soo Ahn; Silvio Aime; Peter Bachert; Jaishri O Blakeley; Kejia Cai; Michael A Chappell; Min Chen; Daniel F Gochberg; Steffen Goerke; Hye-Young Heo; Shanshan Jiang; Tao Jin; Seong-Gi Kim; John Laterra; Daniel Paech; Mark D Pagel; Ji Eun Park; Ravinder Reddy; Akihiko Sakata; Sabine Sartoretti-Schefer; A Dean Sherry; Seth A Smith; Greg J Stanisz; Pia C Sundgren; Osamu Togao; Moriel Vandsburger; Zhibo Wen; Yin Wu; Yi Zhang; Wenzhen Zhu; Zhongliang Zu; Peter C M van Zijl Journal: Magn Reson Med Date: 2022-04-22 Impact factor: 3.737
Authors: Astrid Ellen Grams; Stephanie Mangesius; Ruth Steiger; Ivan Radovic; Andreas Rietzler; Lisa Maria Walchhofer; Malik Galijašević; Julian Mangesius; Martha Nowosielski; Christian Franz Freyschlag; Johannes Kerschbaumer; Elke Ruth Gizewski Journal: Curr Oncol Date: 2021-12-01 Impact factor: 3.677